AR042102A1 - Administracion dermica de un inhibidor de ciclooxigenasa - 2 selectivo soluble en agua - Google Patents
Administracion dermica de un inhibidor de ciclooxigenasa - 2 selectivo soluble en aguaInfo
- Publication number
- AR042102A1 AR042102A1 ARP030104294A ARP030104294A AR042102A1 AR 042102 A1 AR042102 A1 AR 042102A1 AR P030104294 A ARP030104294 A AR P030104294A AR P030104294 A ARP030104294 A AR P030104294A AR 042102 A1 AR042102 A1 AR 042102A1
- Authority
- AR
- Argentina
- Prior art keywords
- active agent
- composition
- subject
- skin
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición farmacéutica para aplicación a un área de piel de un sujeto para el tratamiento local y/o sintético de un trastorno mediado por COX-2, que comprende una lámina de soporte que puede conformarse de forma flexible al área de piel, teniendo la lámina de soporte superficies enfrentadas que están respectivamente distal y proximal a la piel cuando se aplica; y un recubrimiento sobre la superficie proximal de la lámina de soporte, que comprende (a) un adhesivo y (b) un agente activo soluble en agua seleccionado de fármacos o profármacos o sus sales inhibidores de COX-2 selectivos; (tales como valdecoxin, parecoxin), estando el agente activo en una cantidad total terapéuticamente efectiva y disperso en una matriz que comprende de cero a menos de una cantidad efectiva para solubilizar el agente activo en total de uno o más disolventes distintos del adhesivo. Un procedimiento de tratamiento local de un sitio de dolor y/o inflamación que comprende aplicar la composición a una superficie de piel del sujeto, preferiblemente en una localización por encima o adyacente al sitio de dolor y/o inflamación, y dejar la composición colocada durante un período de tiempo efectivo para permitir la administración de una cantidad localmente terapéutica del agente activo, Un procedimiento de tratamiento sistémico de un sujeto que tiene un trastorno mediado por COX-2, que comprende aplicar la composición a una superficie de piel del sujeto, y dejar la composición colocada durante un período de tiempo efectivo para permitir la administración transdérmica de una cantidad terapéutica del agente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42820102P | 2002-11-21 | 2002-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR042102A1 true AR042102A1 (es) | 2005-06-08 |
Family
ID=32393362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104294A AR042102A1 (es) | 2002-11-21 | 2003-11-20 | Administracion dermica de un inhibidor de ciclooxigenasa - 2 selectivo soluble en agua |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040126415A1 (es) |
EP (1) | EP1572166A1 (es) |
JP (1) | JP2006509759A (es) |
AR (1) | AR042102A1 (es) |
AU (1) | AU2003291386A1 (es) |
BR (1) | BR0316463A (es) |
CA (1) | CA2506628A1 (es) |
GT (1) | GT200300249A (es) |
MX (1) | MXPA05004989A (es) |
NL (1) | NL1024830C2 (es) |
PA (1) | PA8589001A1 (es) |
PE (1) | PE20041026A1 (es) |
TW (1) | TW200503787A (es) |
UY (1) | UY28086A1 (es) |
WO (1) | WO2004047814A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004091521A2 (en) | 2003-04-10 | 2004-10-28 | Neurogesx, Inc. | Methods and compositions for administration of trpv1 agonists |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
BRPI0607461A2 (pt) * | 2005-02-14 | 2009-09-08 | Neurogesx Inc | dispositivo para liberação de agonistas de trpv1 |
US20060222690A1 (en) * | 2005-03-30 | 2006-10-05 | Bley Keith R | Low-concentration capsaicin patch and methods for treating neuropathic pain |
DE102005050431A1 (de) * | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
EP2051699B1 (en) * | 2006-05-10 | 2018-09-26 | biolitec Unternehmensbeteiligungs II AG | Photosensitizer formulations for topical applications |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
JP4327841B2 (ja) * | 2006-12-20 | 2009-09-09 | 日東電工株式会社 | 経皮吸収製剤の製造装置および製造方法 |
CA2709808A1 (en) * | 2008-05-21 | 2009-11-26 | Teikoku Pharma Usa, Inc. | Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs |
JP2012020991A (ja) * | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US9814911B2 (en) * | 2011-07-15 | 2017-11-14 | Robert Benson Aylor | Skin and hair treatments |
US20180271813A1 (en) * | 2014-11-10 | 2018-09-27 | Achelios Therapeutics, Inc. | Sprayable analgesic compositions |
KR102042456B1 (ko) * | 2018-03-22 | 2019-11-08 | 크리스탈지노믹스(주) | 경피흡수제제 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0892791B1 (en) * | 1996-04-12 | 2003-03-05 | G.D. Searle & Co. | N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
WO1998018416A1 (en) * | 1996-10-30 | 1998-05-07 | Theratech, Inc. | Fatty acid esters of glycolic acid and its salts as permeation enhancers |
ES2197077T3 (es) * | 1999-03-01 | 2004-01-01 | Amarin Technologies S.A. | Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo. |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
IN191512B (es) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
AU2002306868A1 (en) * | 2001-03-28 | 2002-10-15 | Pharmacia Corporation | Therapeutic combinations for cardiovascular and inflammatory indications |
TNSN03127A1 (fr) * | 2001-05-31 | 2005-12-23 | Pharmacia Corp | Composition d'inhibiteur de cyclo-oxygenase-2-selectif, apte a la penetration dermique |
JP4283507B2 (ja) * | 2002-08-02 | 2009-06-24 | 久光製薬株式会社 | 経皮投与用貼付剤 |
-
2003
- 2003-10-10 US US10/683,943 patent/US20040126415A1/en not_active Abandoned
- 2003-11-07 JP JP2004555394A patent/JP2006509759A/ja not_active Withdrawn
- 2003-11-07 CA CA002506628A patent/CA2506628A1/en not_active Abandoned
- 2003-11-07 WO PCT/US2003/035638 patent/WO2004047814A1/en not_active Application Discontinuation
- 2003-11-07 EP EP03768780A patent/EP1572166A1/en not_active Withdrawn
- 2003-11-07 BR BR0316463-2A patent/BR0316463A/pt not_active IP Right Cessation
- 2003-11-07 AU AU2003291386A patent/AU2003291386A1/en not_active Abandoned
- 2003-11-07 MX MXPA05004989A patent/MXPA05004989A/es unknown
- 2003-11-19 PA PA20038589001A patent/PA8589001A1/es unknown
- 2003-11-20 TW TW092132570A patent/TW200503787A/zh unknown
- 2003-11-20 GT GT200300249A patent/GT200300249A/es unknown
- 2003-11-20 AR ARP030104294A patent/AR042102A1/es unknown
- 2003-11-20 NL NL1024830A patent/NL1024830C2/nl not_active IP Right Cessation
- 2003-11-21 UY UY28086A patent/UY28086A1/es not_active Application Discontinuation
- 2003-11-21 PE PE2003001182A patent/PE20041026A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GT200300249A (es) | 2004-07-12 |
EP1572166A1 (en) | 2005-09-14 |
WO2004047814A1 (en) | 2004-06-10 |
CA2506628A1 (en) | 2004-06-10 |
NL1024830A1 (nl) | 2004-05-26 |
UY28086A1 (es) | 2004-06-30 |
NL1024830C2 (nl) | 2006-03-06 |
TW200503787A (en) | 2005-02-01 |
MXPA05004989A (es) | 2005-08-02 |
PA8589001A1 (es) | 2005-02-04 |
PE20041026A1 (es) | 2005-02-05 |
AU2003291386A1 (en) | 2004-06-18 |
BR0316463A (pt) | 2005-10-11 |
JP2006509759A (ja) | 2006-03-23 |
US20040126415A1 (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042102A1 (es) | Administracion dermica de un inhibidor de ciclooxigenasa - 2 selectivo soluble en agua | |
KR101741294B1 (ko) | 미소 돌기가 형성된 어레이를 갖는 디바이스 | |
MXPA04001491A (es) | Dispositivo de liberacion de farmaco erosionable mucoadhesivo para la administracion controlada de compuestos activos farmaceuticos y otros compuestos activos. | |
JP4824681B2 (ja) | 無針微小突起システム | |
BRPI0415466A (pt) | método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos | |
ES2188907T3 (es) | Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas. | |
DK1009393T3 (da) | Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning | |
KR20070007850A (ko) | 국소용 메타돈 조성물 및 그의 사용 방법 | |
BR9815378A (pt) | Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo. | |
ATE288743T1 (de) | Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist | |
DK1333818T3 (da) | Transdermalt indgivelsessystem med titrebar dosering | |
AR042104A1 (es) | Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa -2 | |
AR046697A1 (es) | Metodo y sistema de administracion transdermica de agente asistido por frecuencia | |
BRPI0509901A (pt) | aparelho e método para liberação transdérmica de agentes com base em fentanila | |
BRPI0417437A (pt) | dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose | |
ATE396714T1 (de) | Transdermales therapeutisches system mit verbessertem langzeittragekomfort | |
BR0316436A (pt) | Emplastro inibidor seletivo de ciclooxigenase-2 | |
MX2009008993A (es) | Dispositivo para la administracion percutanea de bisoprolol. | |
ATE72129T1 (de) | Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung. | |
JP2010018564A (ja) | 抗癌剤治療中の皮膚用貼付材 | |
TW200738252A (en) | Apparatus and method for transdermal delivery of Epoetin-based agents | |
DOP2003000758A (es) | Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua | |
DOP2003000759A (es) | Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2 | |
ES2179658T3 (es) | Uso de oxazolidinonas para la preparacion de un medicamento de suministro transdermico. | |
ES2105334T3 (es) | Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |